Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1320 (LINC01320)

Target
LINC01320
Molecular classification
Other, Long non-coding RNA (lncRNA)
01

Overview

Long intergenic non-protein coding RNA 1320 (LINC01320) is a human long non-coding RNA (lncRNA) that does not code for proteins but plays a role in the regulation of gene expression and cellular functions[3][5]. It has been found to be overexpressed in several cancers, including ovarian cancer, pancreatic cancer, and gastric cancer, where it is associated with increased cell proliferation, migration, invasion, and poor prognosis[2][4]. LINC01320 can act as a molecular sponge for microRNA miR-324-3p, thereby modulating the expression of genes involved in tumor progression, and can directly interact with protein factors such as PURB to repress transcription of genes like DDB2[2][4]. Its high expression is implicated in oncogenic processes, and studies suggest it may serve as both a prognostic biomarker and a prospective therapeutic target for malignant disease[2][4]. No approved drugs are known to directly target LINC01320 at this time.

Other names
lncRNA 74.1LINC01317LINC01320long intergenic nonprotein coding RNA 1320
02

Mechanism of action

Acts as a molecular sponge for microRNAs (e.g., miR-324-3p); Interacts with proteins such as purine-rich element binding protein B (PURB); Recruits protein complexes to promoter regions to regulate downstream gene (e.g., DDB2) transcription.

03

Biological functions

Regulation of gene expressionModulation of cell proliferationRegulation of cell migration and invasionRegulation of apoptosis
04

Disease associations

CancerOvarian cancerPancreatic cancerGastric cancerOther malignancies
05

Biomarkers

Expression level of LINC01320 as a prognostic marker in cancer tissuesLINC01320/miR-324-3p axis activity

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1320 (LINC01320).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1320 (LINC01320).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call